South Texas Accelerated Research Therapeutics
In research, South Texas Accelerated Research Therapeutics stands highest in Health Sciences (#10,523 of 16,688 worldwide) and Medicine (#10,714 of 14,558 worldwide), over all time.
- World rank, 2022-now
- #22,084 of 22,385 · #26,975 all time
- Rank in United States
- #3,282 of 3,332
- Research works
- 273 ▲ 9% vs 2018-21
- Citations
- 6.9k 25.4 per fractional work
- Top-10% rate
- 14.7% all institutions 10.0%
- vs its own fields
- 0.97× 1.00× is exactly expected
- Open access
- 29% world 40%
- International
- 35% world 18%
What is South Texas Accelerated Research Therapeutics known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Health SciencesDomain | #10,523 of 16,688 | 20.0% | 160 | |
| MedicineField | #10,714 of 14,558 | 20.1% | 158 |
Each strip is that field's whole ranked pool, with the notch where South Texas Accelerated Research Therapeutics sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which fields of science does South Texas Accelerated Research Therapeutics work in?
In 2022-now, 61% of research at South Texas Accelerated Research Therapeutics is in Health Sciences, 29% in Life Sciences. Its largest fields are Medicine (60%), Biochemistry, Genetics and Molecular Biology (21%), Immunology and Microbiology (7%). It does 2.4× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 22 fields, with their numbers
- Health Sciences4861.3%
- Medicine4760.4%
- Health Professions10.8%
- Nursing00.1%
- Dentistry00.0%
- Life Sciences2329.1%
- Physical Sciences45.0%
- Engineering22.4%
- Physics and Astronomy11.3%
- Computer Science00.5%
- Materials Science00.4%
- Chemistry00.2%
- Mathematics00.1%
- Environmental Science00.1%
- Social Sciences44.6%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.5×. Every wedge is a field page.
All 22 fields, with their numbers
- Immunology and Microbiology6.55×5 works
- Biochemistry, Genetics and Molecular Biology3.94×16 works
- Medicine3.14×47 works
- Pharmacology, Toxicology and Pharmaceutics0.92×0 works
- Physics and Astronomy0.58×1 works
- Economics, Econometrics and Finance0.41×1 works
- Neuroscience0.32×0 works
- Health Professions0.31×1 works
- Psychology0.22×0 works
- Engineering0.16×2 works
- Social Sciences0.16×2 works
- Agricultural and Biological Sciences0.15×0 works
- Chemistry0.15×0 works
- Arts and Humanities0.15×0 works
- Nursing0.14×0 works
- Business, Management and Accounting0.14×0 works
- Materials Science0.12×0 works
- Decision Sciences0.07×0 works
- Computer Science0.06×0 works
- Mathematics0.06×0 works
- Dentistry0.05×0 works
- Environmental Science0.01×0 works
- Immunology and Microbiology 6.5×
- Biochemistry, Genetics and Molecular Biology 3.9×
- Medicine 3.1×
- Pharmacology, Toxicology and Pharmaceutics 0.9×
- Physics and Astronomy 0.6×
- Economics, Econometrics and Finance 0.4×
- Neuroscience 0.3×
- Health Professions 0.3×
- Psychology 0.2×
- Engineering 0.2×
- Social Sciences 0.2×
- Agricultural and Biological Sciences 0.1×
- Chemistry 0.1×
- Arts and Humanities 0.1×
- Nursing 0.1×
- Business, Management and Accounting 0.1×
- Materials Science 0.1×
- Decision Sciences 0.1×
- Computer Science 0.1×
- Mathematics 0.1×
- Dentistry 0.1×
- Environmental Science 0.0×
Who are the top researchers at South Texas Accelerated Research Therapeutics?
Ranked on the quality score, Amita Patnaik, Kyriakos P. Papadopoulos and Anthony W. Tolcher lead among researchers whose main affiliation is South Texas Accelerated Research Therapeutics.
- 1
Amita Patnaik
United States · #34,782 worldwide 36k citations · 739 works
- 2
Kyriakos P. Papadopoulos
United States · #39,598 worldwide 18k citations · 763 works
- 3
Anthony W. Tolcher
United States · #88,271 worldwide 25k citations · 945 works
- 4
Drew Warren Rasco
United States · #90,188 worldwide 8.7k citations · 466 works
- 5
Muralidhar Beeram
United States · #169,526 worldwide 7k citations · 170 works
- 6
Michael J. Wick
United States · #278,694 worldwide 3.8k citations · 298 works
- 7
Nehal J. Lakhani
United States · #329,869 worldwide 4.8k citations · 310 works
- 8
Sreenivasa Rao Chandana
United States · #660,826 worldwide 3.2k citations · 119 works
- 9
Lon S. Smith
United States · #921,338 worldwide 3.9k citations · 70 works
- 10
Alyssa D. Moriarty
United States · #959,433 worldwide 579 citations · 62 works
Which keywords describe research at South Texas Accelerated Research Therapeutics?
By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Breast Cancer, Immunotherapy, Tumor Microenvironment, Targeted Therapy, Metastatic Breast Cancer, Clinical Trials and Cell Cycle Control.
- Tumor Targeting
- Lymphoma
- EGFR Mutations
- Treatment Guidelines
- Transcriptional Regulation
- Genetic Mutations
- Prognostic Factors
- Biomarkers
- Antibody Engineering
- Glycosylation
- Genomic Profiling
- Trastuzumab
- Immune Checkpoint Blockade
- Cancer Immunotherapy
- CDK4/6 Inhibitors
- Cell Cycle Control
- Cancer
- Metastatic Breast Cancer
- Tumor Microenvironment
- Breast Cancer
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Clinical Trials
- Cancer Therapy
- Metastatic
- Palbociclib
- HER2
- PD-1 and PD-L1
- Tumor Regression
- Monoclonal Antibodies
- Therapeutic Antibodies
- Fc Receptors
- Molecular Subtypes
- PET Imaging
- Immunity
- Resistance Mechanisms
- ALK Inhibitors
- Gene Therapy
- Metastasis
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy11▲ 19×14 topics
- Breast Cancer10▲ 53×6 topics
- Immunotherapy9▲ 17×14 topics
- Tumor Microenvironment7▲ 20×8 topics
- Targeted Therapy7▲ 40×5 topics
- Metastatic Breast Cancer6▲ 130×2 topics
- Clinical Trials6▲ 11×7 topics
- Cancer5▲ 4.8×22 topics
- Cancer Therapy5▲ 10×14 topics
- Cell Cycle Control5▲ 175×2 topics
- Metastatic5▲ 90×2 topics
- CDK4/6 Inhibitors5▲ 207×1 topic
- Palbociclib5▲ 207×1 topic
- Cancer Immunotherapy4▲ 38×3 topics
- HER24▲ 176×1 topic
- Immune Checkpoint Blockade4▲ 49×1 topic
- PD-1 and PD-L14▲ 49×1 topic
- Trastuzumab4▲ 112×1 topic
- Tumor Regression4▲ 47×2 topics
- Genomic Profiling4▲ 48×2 topics
- Monoclonal Antibodies4▲ 54×3 topics
- Glycosylation4▲ 42×2 topics
- Therapeutic Antibodies4▲ 65×2 topics
- Antibody Engineering4▲ 81×1 topic
- Fc Receptors4▲ 81×1 topic
- Biomarkers3▲ 6.0×4 topics
- Molecular Subtypes3▲ 46×2 topics
- Prognostic Factors3▲ 9.0×12 topics
- PET Imaging3▲ 20×4 topics
- Genetic Mutations3▲ 7.6×11 topics
- Immunity2▲ 7.9×6 topics
- Transcriptional Regulation2▲ 19×7 topics
- Resistance Mechanisms2▲ 36×2 topics
- Treatment Guidelines2▲ 14×3 topics
- ALK Inhibitors2▲ 48×1 topic
- EGFR Mutations2▲ 48×1 topic
- Gene Therapy2▲ 15×4 topics
- Lymphoma2▲ 19×2 topics
- Metastasis2▲ 8.6×8 topics
- Tumor Targeting2▲ 16×3 topics
Which research topics does South Texas Accelerated Research Therapeutics publish most on?
By volume in 2022-now: Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Cancer Immunotherapy and Biomarkers and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 5 works
- 2 HER2/EGFR in Cancer Research Oncology 4 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 4 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 4 works
- 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 6 CAR-T cell therapy research Oncology 2 works
- 7 Cancer Research and Treatments Biotechnology 2 works
- 8 Colorectal Cancer Treatments and Studies Oncology 2 works
- 9 Cancer Genomics and Diagnostics Cancer Research 2 works
- 10 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 2 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has South Texas Accelerated Research Therapeutics's research output changed?
Output in 2022-2025 was 9% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is South Texas Accelerated Research Therapeutics as a percentage of every work published that year, 0.00032% in 2024.
Fractional works of South Texas Accelerated Research Therapeutics over all fractional works that year. How the balance of science has shifted.
Other research institutions in San Antonio
- The University of Texas at San Antonio
- Southwest Research Institute
- Trinity University
- San Antonio College
- Texas Biomedical Research Institute
- Quality Research
- University Health System
- University of the Incarnate Word
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about South Texas Accelerated Research Therapeutics. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
